PDM-35

3,5-dimethyl-2-phenylmorpholine (PDM-35)
Legal status
Legal status	CA: Unscheduled ; DE: NpSG (Industrial and scientific use only) ; UK: Under Psychoactive Substances Act ; US: Analogue to a Schedule I/II drug (possibly, in some states);
Identifiers
	IUPAC name 3,5-dimethyl-2-phenylmorpholine;
CAS Number	1218345-44-8;
PubChem CID	43367115;
DrugBank	Provide Please Provide;
UNII	B5FRU2US8C;
	Provide&page2=PDM-35 (verify)

2-Phenyl-3,5-dimethylmorpholine is a drug with stimulant and anorectic effects, related to phenmetrazine. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.^[1]

References

↑ HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.

[1]

PDM-35

See also

References